US Patent 11773156 Anti-hemagglutinin antibodies and methods of use thereof
Patent 11773156 was granted and assigned to Regeneron Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 28, 2020
Date of Patent
October 3, 2023
Patent Applicant
Patent Application Number
17082375
Patent Citations
Patent Inventor Names
Christos Kyratsous
Alina Baum
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11773156 Anti-hemagglutinin antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.